The major factors driving the growth of Pharmaceutical Membrane Filtration Market are the increasing adoption of single-use technologies and the growing demand for nanofiltration. Geographical expansion in countries such as Singapore, France, China, and India and the demand for polyamide track-etched membranes in ultrafiltration are likely to provide growth opportunities for players in the market.
The global pharmaceutical membrane filtration market is projected to reach USD 10.2 billion by 2025 from USD 5.8 billion
in 2020, growing at a CAGR of 12.0% during the forecast period.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031
KEY MARKET DYNAMICS
1
DRIVERS
1 Increasing usage of single-use technologies
2 Nanofiltration technology
2
OPPORTUNITIES
1 Geographical expansion
2 Ultrafiltration track-etched membranes
3
BURNING ISSUES
1 Intense competition in the market—a critical barrier
for new entrants
4
IMPACT OF COVID-19 OUTBREAK ON THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET
1 Impact on the pharmaceutical membrane filtration
market
Market Segmentation :
On the basis of product, the market is segmented
into filters, systems, and accessories. Filters formed the largest product
segment in this market owing to the high and growing use of different types of
membrane filters for various filtration applications in the biopharmaceutical
manufacturing industry.
On the basis of technique, the
pharmaceutical membrane filtration market is segmented into microfiltration,
ultrafiltration, nanofiltration, reverse osmosis, and ion exchange.
Microfiltration segment accounted for the largest share of the market in 2019.
Microfiltration is one of the oldest and most commonly used techniques for the
separation of large-molecular-weight suspended or colloidal compounds from
dissolved solids.
On the basis of application, the market is segmented
into final product processing, raw material filtration, cell separation, water
purification, and air purification. Final product processing was the largest
application segment in the market in 2019. The increasing production of
generics, rapid growth in the biopharmaceutical industry, and the increasing
adoption of membrane filters in protein purification, sterile filtration, and
viral clearance processes are the major factors driving the growth of this
application segment.
Regional Analysis:
The global pharmaceutical membrane filtration market
is segmented into North
America, Europe,
the Asia Pacific,
and the Rest of the World. In 2019, North
America was the largest market for pharmaceutical
membrane filtration, followed by Europe.
The large share of North
America can be attributed to several factors, such as
the presence of key biopharmaceutical manufacturing facilities in the region
and the significant spending on research and development activities in the US.
Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031
Recent Developments:
·
In 2020, Merck invested USD 280.3 million in a new
facility—the Merck Biotech Development Center in Corsier-sur-Vevey,
Switzerland.
·
In 2019, Koch Membrane Systems launched Sani-Pro
Spiral Element Product Line.
·
In 2018, Pall Corporation partnered with
BioSciencesCorp to provide drug manufacturers with direct access to Pall
Biotech’s downstream technologies, including pharmaceutical membrane
filtration.
Top Key Players:
The major companies operating in the pharmaceutical
membrane filtration market include Merck (Germany),
Danaher (US) and Sartorius Stedim Biotech (France).
